A 71-year-old man with gallbladder adenocarcinoma and no history of dyslipidemia presented with serum triglyceride level of 912 mg/dL after two months of starting Capecitabine. The lipemia due to elevated triglyceride also led to hemolysis, causing analytical interference to other biochemical tests and complete blood count.